FDA approvals of generic drugs: Impact on the diversion of opioid analgesic with a potential for abuse

Journal of Opioid Management

Volumn 5, Issue 2, 2009, Pages 81-87

  Inciardi, James A ^a   Surratt, Hilary L ^a   Stivers, Yamilka ^a   Cicero, Theodore J ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diversion; Fentanyl; Generics; Opioids; Oxycodone

Indexed keywords

FENTANYL; GENERIC DRUG; OPIATE; OXYCODONE;

ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG ABUSE; DRUG APPROVAL; DRUG FORMULATION; DRUG INDICATION; DRUG LABELING; DRUG MARKETING; DRUG TRAFFIC; FOOD AND DRUG ADMINISTRATION; OPIATE ADDICTION; POSTMARKETING SURVEILLANCE; PRESCRIPTION; RISK ASSESSMENT; TREND STUDY;

EID: 65749112177     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2009.0009     Document Type: Article

References (45)

1. Chambers CD, Inciardi JA, Petersen DM, et al.: Chemical Dependencies: Patterns, Costs, and Consequences. Athens, OH: Ohio University Press, 1987.
2. Chambers CD, Inciardi JA, Siegal HA: Chemical Coping: A Report on Legal Drug Use in the United States. New York: Spectrum Publications, 1975.
3. Hughes R, Brewin R: The Tranquilizing of America: Pill Popping and the American Way of Life. New York: Harcourt Brace Jovanovich, 1979.
4. Mondanaro J: Chemically Dependent Women: Assessment and Treatment. Lexington, MA: Lexington Books, 1989.
5. Weil A, Rosen W: Chocolate to Morphine: Understanding Mind-Active Drugs. Boston: Houghton Mifflin Company, 1983.
6. Grinspoon L, Hedblom P: The Speed Culture: Amphetamine Use and A buse in America. Cambridge, MA: Harvard University Press, 1975.
7. Inciardi JA: Patterns of Methaqualone Abuse. In U.S. Congress (ed.): Methaqualone Traffic, Abuse, and Regulation. Washington, DC: U.S. Government Printing Office, 1973: 109-115.
8. Inciardi JA, Petersen DM, Chambers CD: Methaqualone abuse patterns, diversion paths and adverse reactions. J Fla Med Assoc. 1974; 61: 279-283.
9. Klee H (ed.): Amphetamine Misuse: International Perspectives on Current Trends. Amsterdam: Harwood Academic Publishers, 1997.
10. Zacny J, Bigelow G, Compton P, et al.: College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug Alcohol Depend. 2003; 69(3): 215-232.
11. McCabe SE, Knight JR, Teter CJ, et al.: Non-Medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction. 2005; 99(1): 96-106.
12. McCabe SE, Teter CJ, Boyd CJ: The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse. 2004; 39(7): 1095-1116.
13. McCabe SE, Teter CJ, Boyd CJ, et al.: Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addictive Behav. 2005; 30, 789-805.
14. Meier B: Pain Killen A "Wonder" Drug's Trail of Addiction and Death. Emmaus, PA: Rodale Press, 2003.
15. National Institute on Drug Abuse: NIDA infoFacts: Methylphenidate (Ritalin). Washington, DC: U.S. Department of Health & Human Services, 2004.
16. Office of National Drug Control Policy: Press release: U.S. drug prevention, Treatment, enforcement agencies take on "doctor shoppers," "pill mills," March 1. Available at www.whitehousedrugpolicy.gov/news/press04/030104.html. Accessed July 25, 2006.
17. McCarthy M: Prescription drug abuse up sharply in the USA. The Lancet. 2007-1 369: 1505-1506.
18. Substance Abuse and Mental Health Services Administration, & Office of Applied Studies: Results from the 2007 National Survey on Drug Use and Health: National Findings. (Office of Applied Studies, NSDUH). Rockville, MD: Substance Abuse and Mental Health Services Administration, & Office of Applied Studies, 2008.
19. Substance Abuse and Mental Health Services Administration, & Office of Applied Studies: Treatment Episode Data Set (Teds) 1992-2002: National Admissions to Substance Abuse Treatment Services. DASIS Series: S-23, DHHS Publication No. (SMA) 04-3965. Rockville, MD: Substance Abuse and Mental Health Services Administration, & Office of Applied Studies, 2004.
20. Substance Abuse and Mental Health Services Administration, & Office of Applied Studies: Benzodiazepines in Drug Abuse-Related Emergency Department Visits: 1995-2002. The DAWN report, 2004. Available at http://dawninfo.samhsa.gov/old_dawn/pubs_94_02/shortreports/files/ DAWN_tdr_benzo.pdf. Accessed October 27, 2008.
21. Cicero TJ, Inciardi JA, Muñoz A: Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004. Pain. 2005; 6(10): 662-672.
22. Hench D: Generic OxyContin Worries Authorities. Miami Herald, January 13, 2004.
23. Drug Enforcement Administration: Drug alert: Generic OxyContin® emerges as new threat. Available at www.dea.gov/concern/ generic_oxycodone_factsheetp.html. Accessed April 15, 2004.
24. Inciardi JA, Surratt HL, Kurtz SP, et al.: Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007; 8(2): 171-183.
25. Cicero TJ, Dart RC, Inciardi JA, et al.: The development of a comprehensive risk-management program for prescription opioid analgesics: Researched abuse, diversion and addiction-related surveillance (RADARS®). Pain Med. 2007; 8(2): 157-170.
26. Smith MY, Schneider ME, Wentz A, et al.: Quantifying morbidity associated with the abuse and misuse of opioid analgesics: A comparison of two approaches. J Clin Toxicol. 2007; 45(1): 23-30.
27. Bailey JE, Barton PL, Lezotte D, et al.: The effect of FDA approval of a generic competitor to OxyContin® (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. Drug Alcohol Depend. 2006; 84(2): 182-187.
28. Compton WM, Volkow ND: Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006; 81: 103-107.
29. CASA (The National Center on Addiction and Substance Abuse at Columbia University): Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S. New York: The National Center on Addiction and Substance Abuse at Columbia University, 2005.
30. Drug Topics: The top 200 prescriptions for 2007 by prescriptions dispensed. Available at www.drugtopics.com/. Accessed April 17, 2007.
31. Joranson DE, Ryan KM, Gilson AM, et al.: Trends in medical use and abuse of opioid analgesics. J Am Med Assoc. 2000; 283(13): 1710-1714.
32. Novak S, Nemeth WC, Lawson KA: Trends in medical use and abuse of sustained-release opioid analgesics: A revisit. Pain Med. 2004; 5(1): 59-65.
33. Katz NP, Adams EH, Benneyan JC, et al.: Foundations of opioid risk management. Clin J Pain. 2007; 23(2): 103-118.
34. Gilson AM, Joranson DE: U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002; 18(Suppl. 4): S91-S98.
35. Savage SR, Joranson DE, Covington EC, et al.: Definitions related to the medical use of opioids: Evolution towards universal agreement. J Pain Symptom Manage. 2003; 26(1): 655-667.
36. Cohen MJM, Jasser S, Herron PD, et al.: Ethical perspectives: Opioid treatment of chronic pain in the context of addiction. Clin J Pain. 2002; 18: S99-S107.
37. Mott DA, Cline RR: Exploring generic drug use behavior: The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002; 40(8): 662-674,
38. Druss BG, Marcus SC, Olfson M, et al.: Listening to generic prozac: Winners, losers, and sideliners. Health Affairs. 2004; 23(5): 210-216.
39. Inciardi JA: The War on Drugs III: The Continuing Saga of the Mysteries and Miseries of Intoxication, Addiction, Crime, and Public Policy. Boston, MA: Allyn and Bacon, 2002.
40. Inciardi J: The War on Drugs IV: The Continuing Saga of the Mysteries and Miseries of Intoxication, Addiction, Crime, and Public Policy, 4th ed. Boston: Pearson Education, 2008.
41. Eckholm E: Abuses are found in online sales of medication. New York Times, July 9, 2008.
42. Drug Topics: Top 200 generic drugs by units in 2007. Available at http://drugtopics.modernmedicine.com/drugtopics/data/ artliclestandard//drugtopics/072008/491181/article.pdf. Accessed October 27, 2008.
43. Drug Topics: Top 200 generic drugs by units in 2007. Available at http://drugtopics.modernmedicine.com/drugtopics/data/ articlestandard//drugtopics/072008/491207/article.pdf. Accessed October 27, 2008.
44. Purdue Pharma L.P. v. Endo Pharms, Inc., 438 F3d 1123, 2006, 1135-1137.
45. Purdue Pharma L.P. v. Mallinckrodt, Inc., 1:2006cv13095, 2006.